Clinical work with nanoparticles in malignant brain tumors largely focused on imaging and chemotherapy. »
11/19/19

ICIs administered before CT might enhance cytotoxic effects even in pts with immunorefractory MSS mCRC. »
05/05/20

Alterations in cell-cycle pathway genes associated with worse median PFS. »
11/20/18

Low PD-L1 expression, intratumoral and peritumoral CD8+ density associated with lower grade primary tumor differentiation. »
12/02/19

Combined therapy induced about two times more apoptosis than that of ZFNs alone in SiHa and HeLa cells. »
11/24/19

Most frequently mutated gene: PIK3CA. »
05/28/20

CHT has more favorable AE profile when compared with BCG.

»
03/26/20

Incorporation of PD-1 blockade as third side of our suggested therapy led to noticeable regression in tumor size. »
08/07/20

Feasibility and safety of continuing anticancer treatment during SARS-Cov-2 pandemic. »
08/10/20

Role of hypoxia in the activation of the IL-1β/IL1R1 signaling. »
08/10/20